RxDoctor Payments Data

Mario Galdames, MD

Geriatric Medicine · Sunrise, FLNPI 1831391259

Payments from drug & device makers

$706in general payments, 2019–2025

Across 31 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$120
  • Philips North America LLC$100
  • E.r. Squibb & Sons, L.L.C.$92
  • Astellas Pharma US Inc$66
  • Sunovion Pharmaceuticals Inc.$64
  • AbbVie$60
  • plus $203 from 7 others

What the payments were for

  • Food & beverage$703100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$706 in reported general payments places this provider in the 65th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$364,616
Medicare patients
756
Services billed
3,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban217$142,249
RukobiaFostemsavir Tromethamine11$104,147
OzempicSemaglutide56$55,032
TradjentaLinagliptin40$26,996
JardianceEmpagliflozin45$26,228
LinzessLinaclotide33$23,154
XareltoRivaroxaban13$15,378
MyrbetriqMirabegron27$15,020
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$14,906
FarxigaDapagliflozin Propanediol13$13,315
OxycontinOxycodone Hcl11$11,561
EntrestoSacubitril/Valsartan17$11,367
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$10,628
JanumetSitagliptin Phos/Metformin Hcl11$9,427
Janumet XrSitagliptin Phos/Metformin Hcl13$7,880

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$60$23,15433 claims
Johnson & JohnsonXarelto$48$15,37813 claims
Astellas Pharma US IncMyrbetriq$66$15,02027 claims
GSKTrelegy Ellipta$15$14,90618 claims
NovartisEntresto$54$11,36717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Sunrise

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →